Differences

This shows you the differences between two versions of the page.

--- samantha_akingbola [2022/05/10 00:04]
liam created
+++ samantha_akingbola [2022/05/10 06:57] (current)
liam
@@ Line 1: / Line 1: @@
 ====== Samantha Akingbola ======
+{{ ::1551486519815.jpeg?200|}}
 **Samantha Akingbola** is a Canadian epidemiologist based in [[canada:ontario:Toronto]], [[canada:Ontario]].
+===== Education =====
+Akingbola attended the [[University of Ottawa]] from 2009-2013 where she received her Bachelor of Arts in Health Sciences. She then attended the [[State University of New York at Albany]] from 2014-2015 where she received her Master of Public Health.
+===== Career and Affiliations =====
+==== New York State Department of Health ====
+In 2015, Akingbola worked at the [[New York State Department of Health]] as a public health intern in the Bureau of Communicable Disease Control, and then the office of the Medical Director of the Center for Environmental Health.((//Samantha Akingbola, MPH.// LinkedIn. Retrieved May 9, 2022, from https://www.linkedin.com/in/samantha-akingbola-mph-67973516a/))
+==== Public Health England ====
+Akingbola worked for [[Public Health England]] between June 2016 and June 2018.((Akingbola, S., Saunders, K., Yelloly, J., & Dennis, N. (2017, January). //A Summary of Child Health Profiles in the West Midlands.// Learning for Public Health West Midlands. https://web.archive.org/web/20220509222500/https://webcache.googleusercontent.com/search?q=cache%3Ahttps%3A%2F%2Fwww.lfphwm.org.uk%2Flibrary%2Fsearch-results%2Fdoc_download%2F859-a-summary-of-child-health-profiles-in-the-west-midlands))
+==== Heart & Stroke Foundation ====
+From September 2018 - February 2019, Akingbola worked as an intake specialist at the [[Heart & Stroke Foundation]]. The foundation is funded by [[pharmaceutical_companies:Allergan]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[Canadian National Railway]] (a [[Bill Gates]] company), [[medical_technology_companies:Edwards Lifesciences]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novo Nordisk]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Roche]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Servier]], and [[Shoppers Drug Mart]].((//Our partners.// Heart and Stroke Foundation of Canada. Retrieved May 9, 2022, from https://archive.ph/LR0SK))
+==== Public Health Ontario ====
+Akingbola worked at [[Public Health Ontario]] from March 2019 - December 2020.((van Ingen, T., Akingbola, S., Brown, K. A., Daneman, N., Buchan, S. A., & Smith, B. T. (2021). //Neighbourhood-level risk factors of COVID-19 incidence and mortality.// medRxiv. Preprint. https://doi.org/10.1101/2021.01.27.21250618))
+==== Toronto Public Health ====
+Akingbola is an epidemiologist at [[Toronto Public Health]].((Yuan, P., Aruffo, E., Tan, Y., Yang, L., Ogden, N. H., Fazil, A., & Zhu, H. (2022). //Projections of the transmission of the Omicron variant for Toronto, Ontario, and Canada using surveillance data following recent changes in testing policies.// Infectious Disease Modelling, 7(2), 83–93. https://doi.org/10.1016/j.idm.2022.03.004)) ((//Samantha Akingbola, MPH.// LinkedIn. Retrieved May 9, 2022, from https://www.linkedin.com/in/samantha-akingbola-mph-67973516a/))
+==== Ontario COVID-19 Science Advisory Table ====
+Akingbola is an observer on the Modelling Consensus Table, in partnership with the [[Ontario COVID-19 Science Advisory Table]].((//Our Partners.// Ontario COVID-19 Science Advisory Table. Retrieved May 9, 2022, from https://web.archive.org/web/20220509143427/https://covid19-sciencetable.ca/our-partners/))